Louisville Medicine Volume 65, Issue 7 | Page 17

FEATURE about the size of the incision? Well …, the small incision is part of it but in the overall picture is probably not the most important factor. But from both the patient’s perception point and marketing view, undoubtedly it is the selling point as we see how the surgical websites, TV or even highway billboard advertising obsess with it! Since the inception over two decades ago, LICS procedures have been the subject of intense scrutiny and controversy by the surgical community, as reflected in national and international meetings. Even now, cardiac surgeons are divided in two distinct camps, and their antagonistic positions on the subject are maintained fiercely. Furthermore, probably more effort has been placed in trying to prove the advancements wrong rather than in cautiously promoting and improving these new options. This “all or none” approach to new procedures is not unusual in the cardiac surgery community, with other clear examples of “developmental arrest” lately being the lack of acceptance and advancement of coronary bypass surgery without the use of the heart lung machine, the so called “off pump” or OPCAB operations. Nobody can deny the deleterious effects of the use of the “heart-lung” machine in patients with renal and liver dysfunction, poor lungs, hematologic disease, post transplantation, aortic calcification or in the Jehovah’s Witness population. It is clear to most surgeons that OPCAB is a more technically demanding, stressful procedure and therefore, requires a motivated, interested and skillful surgeon to do them. But most surgeons with the adequate training and interest could do them. It makes sense to me that the subgroups of patients I mentioned will do better without the use of CPB, and many studies have shown that (4,5). Other studies, however some of them with a questionable design, patient selection and/or surgeon experience have shown otherwise (6), again feeding the “all or none” mentality and minimizing the value of OPCAB as an alternative option. In the USA, sadly enough, less than 15 percent of coronaries are performed without the pump. Looking at the LICS acceptance argument from the other side, I can point to some of the factors I see as supporting the reluctance to change, or at least, slowing the acceptance of the “MICS” or “LICS” approaches. The dogma in our specialty has always been to simplify the techniques and to improve outcomes. So, why make a cardiac operation more complicated than it is? Without doubt, small incision procedures (Pictures # 1-2) have more steps and allows for more room for mistakes, especially during the learning curve. Moreover, cardiac surgeons develop confidence and acquire experience at a low pace compared to other specialties. For example, it will take many years for the average CV surgeon to acquire the adequate volume of cases and experience to be comfortable performing complex mitral valve repairs or aortic surgery. To expect the average surgeon to perform complex repairs through alternative LICS approaches early in his/her career may not be realistic, or even safe, except for Standard approach for LICS mitral valve repair ( image with permission of Edwards, Inc, Irvine, CA) few exceptions. The price to be paid, for both patient and surgeon, could be steep. Other factors related to adoption could be the av- erage age of heart surgeons in the U.S., which is well over 50 years. Acceptance to practice change may not be well received, distinctly if more training is required with an inherent risky learning curve, longer procedures, more stress, jeopardy of referrals and of course, all … for the same pay! Therefore, the incentive is not there. It is contradicting and very surprising to me that cardiac surgeons are willing to accept and promote the extremes of care; i.e. the most accepted modalities for the treatment of symptomatic severe aortic stenosis (AS) are both the proven (more than 50 years) yet most invasive full open sternotomy aortic valve replacement (SAVR) and the minimalistic but promising and now frequently used per- cutaneous valve implants (TAVR) for higher risk patients, yet most surgeons still debate and argue against the use and try to fight off mini AVR operations, which are less invasive, easily reproducible and provide great results and patient satisfaction. The modern trend is that all procedures and operations are be- coming less invasive. Even many operations have now become per- cutaneous procedures in riskier patients, such as TAVR (trans-aortic valve replacement), Angio-Vac (tumors and clots suctioned through catheters) and others. It is obvious that patients are looking at other options to avoid open surgery. Even if those options are less than perfect, some with a poorer overall outcome and potentially requir- ing multiple other procedures in the future at a higher cumulative risk, patients may consider them if offered. The perfectionist view, our cardiac surgery view, is based on offering the best possible procedure available, a good technical result as well as a document- (continued on page 16) DECEMBER 2017 15